In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 4, 1998, Pages 497-502

  Lass Florl C ^a   Kofler, G ^a   Kropshofer, G ^a   Hermans, J ^b   Kreczy, A ^a   Dierich, M P ^a   Niederwieser, D ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS TERREUS; CLINICAL ARTICLE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; RISK FACTOR;

AMPHOTERICIN B; ANEMIA, APLASTIC; ANTIBIOTICS, ANTIFUNGAL; ASPERGILLOSIS; ASPERGILLUS; BURKITT LYMPHOMA; CELLS, CULTURED; HUMANS; LEUKEMIA; MICROBIAL SENSITIVITY TESTS; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 0031687627     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.4.497     Document Type: Article

References (24)

1. Denning, D. W. & Stevens, D. A. (1990). Antifungal and surgical treatment of invasive aspergillosis: review of 2121 published cases. Reviews of Infectious Diseases 12, 1147-201.
2. Denning, D. W., Follansbee, S. E., Scolaro, M., Norris, S., Edelstein, H. & Stevens, D. A. (1991). Pulmonary aspergillosis in the acquired immunodeficiency syndrome. New England Journal of Medicine 324, 654-62.
3. Denning, D. W. (1994). Invasive aspergillosis in immunocompromised patients. Current Opinion in Infectious Diseases 7, 456-62.
4. Anaissie, E. (1992). Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clinical Infectious Diseases 14, Suppl. 1, S43-53.
5. Denning, D. W. (1991). Epidemiology and pathogenesis of systemic fungal infections in the immunocompromised host. Journal of Antimicrobial Chemotherapy 28, Suppl. B, 1-16.
6. Denning, D. W. (1992). Invasive aspergillosis in AIDS - an overview. Journal de Mycologie Medicale 2, Suppl. 1, 35-41.
7. Peterson, P. K., McGlave, P., Ramsay, N. K. C., Rhame, F., Cohen, E. & Perry, G. S. et al. (1983). A prospective study of infectious diseases following bone marrow transplantation: emergence of Aspergillus and cytomegalovirus as the major causes of mortality. American Infection Control 4, 81-9.
8. Pfaller, M. A. (1992). Epidemiological typing methods for mycoses. Clinical Infectious Diseases 14, Suppl. 7, S4-10.
9. Walsh, T. J. & Pizzo, A. (1988). Treatment of systemic fungal infections: recent progress and current problems. European Journal of Clinical Microbiology and Infectious Diseases 7, 460-75.
10. Denning, D. W. (1994). Treatment of invasive aspergillosis. Journal of Infection 28, Suppl. 1, 25-33.
11. National Committee for Clinical Laboratory Standards. (1992). Reference Method for Broth Dilution Susceptibility Testing of Yeasts: Proposed Standard M27-P. NCCLS, Villanova, PA.
12. Espinel-Ingroff, A., Dawson, K., Pfaller, M., Annaissie, E., Breslin, D., Dixon, D. et al. (1995). Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi. Antimicrobial Agents and Chemotherapy 39, 314-9.
13. Bezwoda, W. R., Seymour, L. & Dansey, R. D. (1995). High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial. Journal of Clinical Oncology 13, 2483-9.
14. Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van der Lelie, H., Bron, D. et al. (1995). Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. New England Journal of Medicine 333, 1540-5.
15. Attal, M., Harousseau, J. L., Stoppa, A. M., Sotto, J. J., Fuzibet J. G., Rossi, F. et al. (1996). A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. New England Journal of Medicine 335, 91-7.
16. Cormican, M. G. & Pfaller, M. A. (1996). Standardization of antifungal susceptibility testing. Journal of Antimicrobial Chemotherapy 38, 561-78.
17. Rex, J. H., Pfaller, M. A., Rinaldi, M. G., Polak, A. & Galgiani, J. N. (1993). Antifungal susceptibility testing. Clinical Microbiology Reviews 6, 367-81.
18. Bryce, E. A., Roberts, F. J., Sekhon, A. S. & Coldman, A. J. (1992). Yeast in blood cultures. Evaluation of factors influencing outcome. Diagnostic Microbiology and Infectious Disease 15, 233-7.
19. Tracy, S. L., McGinnis, M. R., Peacock, J. E., Cohen, M. S. & Walker, D. H. (1983). Disseminated infection by Aspergillus terreus. American Journal of Clinical Pathology 80, 728-33.
20. Hara, K. S., Ryu, J. H., Lie, J. T. & Roberts, G. D. (1989). Disseminated Aspergillus terreus infection in immunocompromised hosts. Mayo Clinic Proceedings 64, 770-5.
21. Russack, V. (1990). Aspergillus terreus myocarditis: report of a case and review of the literature. American Journal of Cardiovascular Pathology 3, 275-79.
22. Kalina, P. H. & Campbell, R. J. (1991). Aspergillus terreus endophthalmitis in a patient with chronic lymphocytic leukemia. Archives of Ophthalmology 109, 102-3.
23. Tritz, D. M. & Woods, G. L. (1993). Fatal disseminated infection with Aspergillus terreus in immunocompromised hosts. Clinical Infectious Diseases 16, 118-22.
24. Bodey, G. P. & Vartivarian, S. (1989). Aspergillosis. European Journal of Clinical Microbiology and Infectious Diseases 8, 413-37.